The N-terminal region of the atypical chemokine receptor ackr2 is a key determinant of ligand binding

Journal of Biological Chemistry

Volumn 289, Issue 18, 2014, Pages 12330-12342

  Hewit, Kay D ^a   Fraser, Alasdair ^a   Nibbs, Robert J B ^a   Graham, Gerard J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS;

CHEMOKINE RECEPTORS; KEY DETERMINANTS; LIGAND BINDING; N-TERMINALS; STRUCTURE/FUNCTION; TYROSINE MOTIFS;

LIGANDS;

ANTIINFLAMMATORY AGENT; BACTERIAL ENZYME; CHEMOKINE; CHEMOKINE RECEPTOR; PEPTIDE; PEPTIDE DERIVATIVE; PROTEIN ACKR2; PROTEINASE; STAPHOPAIN A; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SULFATION;

7-HELIX RECEPTOR; CHEMOKINES; FLOW CYTOMETRY; INFLAMMATION; MUTAGENESIS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINES; CHO CELLS; CRICETINAE; CRICETULUS; CYSTEINE ENDOPEPTIDASES; ENDOCYTOSIS; HEK293 CELLS; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN BINDING; RECEPTORS, CHEMOKINE; RNA INTERFERENCE; SEQUENCE HOMOLOGY, AMINO ACID; SULFATES; TYROSINE;

EID: 84899719775     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.534545     Document Type: Article

References (53)

1. Rot, A., and von Andrian, U. H. (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891-928
2. Mantovani, A. (1999) The chemokine system: redundancy for robust outputs. Immunol. Today 20, 254-257
3. Zlotnik, A., and Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127
4. Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., Mantovani, A., Matsushima, K., Murphy, P. M., Nibbs, R., Nomiyama, H., Power, C. A., Proudfoot, A. E., Rosenkilde, M. M., Rot, A., Sozzani, S., Thelen, M., Yoshie, O., and Zlotnik, A. (2014) International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors. Pharmacol. Rev. 66, 1-79
5. Graham, G. J. (2009) D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes. Eur. J. Immunol. 39, 342-351
6. Graham, G. J., Locati, M., Mantovani, A., Rot, A., and Thelen, M. (2012) The biochemistry and biology of the atypical chemokine receptors. Immunol. Lett. 145, 30-38
7. Graham, G. J., and Locati, M. (2013) Regulation of the immune and inflammatory responses by the "atypical" chemokine receptor D6. J. Pathol. 229, 168-175
8. Mantovani, A., Bonecchi, R., and Locati, M. (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 6, 907-918
9. Nibbs, R. J., Wylie, S. M., Pragnell, I. B., and Graham, G. J. (1997) Cloning and characterization of a novel murine β chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1α receptors, CCR-1, CCR-3, and CCR-5. J. Biol. Chem. 272, 12495-12504
10. Nibbs, R. J., Wylie, S. M., Yang, J., Landau, N. R., and Graham, G. J. (1997) Cloning and characterization of a novel promiscuous human β-chemokine receptor D6. J. Biol. Chem. 272, 32078-32083
11. Borroni, E. M., Cancellieri, C., Vacchini, A., Benureau, Y., Lagane, B., Bachelerie, F., Arenzana-Seisdedos, F., Mizuno, K., Mantovani, A., Bonecchi, R., and Locati, M. (2013) β-Arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6. Sci. Signal. 6, ra30
12. Fra, A. M., Locati, M., Otero, K., Sironi, M., Signorelli, P., Massardi, M. L., Gobbi, M., Vecchi, A., Sozzani, S., and Mantovani, A. (2003) Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J. Immunol. 170, 2279-2282
13. Weber, M., Blair, E., Simpson, C. V., O'Hara, M., Blackburn, P. E., Rot, A., Graham, G. J., and Nibbs, R. J. (2004) The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol. Biol. Cell 15, 2492-2508
14. Madigan, J., Freeman, D. J., Menzies, F., Forrow, S., Nelson, S. M., Young, A., Sharkey, A., Moffett, A., Graham, G. J., Greer, I. A., Rot, A., and Nibbs, R. J. (2010) Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J. Immunol. 184, 3202-3212
15. Martinez de la Torre, Y., Buracchi, C., Borroni, E. M., Dupor, J., Bonecchi, R., Nebuloni, M., Pasqualini, F., Doni, A., Lauri, E., Agostinis, C., Bulla, R., Cook, D. N., Haribabu, B., Meroni, P., Rukavina, D., Vago, L., Tedesco, F., Vecchi, A., Lira, S. A., Locati, M., and Mantovani, A. (2007) Protection against inflammation-and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc. Natl. Acad. Sci. U.S.A. 104, 2319-2324
16. Nibbs, R. J., Kriehuber, E., Ponath, P. D., Parent, D., Qin, S., Campbell, J. D., Henderson, A., Kerjaschki, D., Maurer, D., Graham, G. J., and Rot, A. (2001) The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 158, 867-877
17. McKimmie, C. S., Singh, M. D., Hewit, K., Lopez-Franco, O., Le Brocq, M., Rose-John, S., Lee, K. M., Baker, A. H., Wheat, R., Blackbourn, D. J., Nibbs, R. J., and Graham, G. J. (2013) An analysis of the function and expression of D6 on lymphatic endothelial cells. Blood 121, 3768-3777
18. Codullo, V., Baldwin, H. M., Singh, M. D., Fraser, A. R., Wilson, C., Gilmour, A., Hueber, A. J., Bonino, C., McInnes, I. B., Montecucco, C., and Graham, G. J. (2011) An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. Ann. Rheum. Dis. 70, 1115-1121
19. McKimmie, C. S., Fraser, A. R., Hansell, C., Gutiérrez, L., Philipsen, S., Connell, L., Rot, A., Kurowska-Stolarska, M., Carreno, P., Pruenster, M., Chu, C. C., Lombardi, G., Halsey, C., McInnes, I. B., Liew, F. Y., Nibbs, R. J., and Graham, G. J. (2008) Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J. Immunol. 181, 3353-3363
20. Hansell, C. A., Schiering, C., Kinstrie, R., Ford, L., Bordon, Y., McInnes, I. B., Goodyear, C. S., and Nibbs, R. J. (2011) Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 117, 5413-5424
21. Bazzan, E., Saetta, M., Turato, G., Borroni, E. M., Cancellieri, C., Baraldo, S., Savino, B., Calabrese, F., Ballarin, A., Balestro, E., Mantovani, A., Cosio, M. G., Bonecchi, R., and Locati, M. (2013) Expression of the atypical chemokine receptor D6 in human alveolar macrophages in chronic obstructive pulmonary disease. Chest 143, 98-106
22. Singh, M. D., King, V., Baldwin, H., Burden, D., Thorrat, A., Holmes, S., McInnes, I. B., Nicoll, R., Shams, K., Pallas, K., Jamieson, T., Lee, K. M., Carballido, J. M., Rot, A., and Graham, G. J. (2012) Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am. J. Pathol. 181, 1158-1164
23. Jamieson, T., Cook, D. N., Nibbs, R. J., Rot, A., Nixon, C., McLean, P., Alcami, A., Lira, S. A., Wiekowski, M., and Graham, G. J. (2005) The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6, 403-411
24. Martinez de la Torre, Y., Locati, M., Buracchi, C., Dupor, J., Cook, D. N., Bonecchi, R., Nebuloni, M., Rukavina, D., Vago, L., Vecchi, A., Lira, S. A., and Mantovani, A. (2005) Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur. J. Immunol. 35, 1342-1346
25. Whitehead, G. S., Wang, T., DeGraff, L. M., Card, J. W., Lira, S. A., Graham, G. J., and Cook, D. N. (2007) The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am. J. Respir Crit. Care Med. 175, 243-249
26. Nibbs, R. J., Gilchrist, D. S., King, V., Ferra, A., Forrow, S., Hunter, K. D., and Graham, G. J. (2007) The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J. Clin. Invest. 117, 1884-1892
27. Di Liberto, D., Locati, M., Caccamo, N., Vecchi, A., Meraviglia, S., Salerno, A., Sireci, G., Nebuloni, M., Caceres, N., Cardona, P. J., Dieli, F., and Mantovani, A. (2008) Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J. Exp. Med. 205, 2075-2084
28. Vetrano, S., Borroni, E. M., Sarukhan, A., Savino, B., Bonecchi, R., Correale, C., Arena, V., Fantini, M., Roncalli, M., Malesci, A., Mantovani, A., Locati, M., and Danese, S. (2010) The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut 59, 197-206
29. Graham, G. J., and McKimmie, C. S. (2006) Chemokine scavenging by D6: a movable feast? Trends Immunol. 27, 381-386
30. Lee, K. M., McKimmie, C. S., Gilchrist, D. S., Pallas, K. J., Nibbs, R. J., Garside, P., McDonald, V., Jenkins, C., Ransohoff, R., Liu, L., Milling, S., Cerovic, V., and Graham, G. J. (2011) D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 118, 6220-6229
31. Lee, K. M., Nibbs, R. J., and Graham, G. J. (2013) D6: the "crowd controller" at the immune gateway. Trends Immunol. 34, 7-12
32. Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R., Cayabyab, M., Gerard, N. P., Gerard, C., Sodroski, J., and Choe, H. (1999) Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96, 667-676
33. Cormier, E. G., Persuh, M., Thompson, D. A., Lin, S. W., Sakmar, T. P., Olson, W. C., and Dragic, T. (2000) Specific interaction of CCR5 aminoterminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U.S.A. 97, 5762-5767
34. Farzan, M., Vasilieva, N., Schnitzler, C. E., Chung, S., Robinson, J., Gerard, N. P., Gerard, C., Choe, H., and Sodroski, J. (2000) A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J. Biol. Chem. 275, 33516-33521
35. Wang, J., Guan, E., Roderiquez, G., Calvert, V., Alvarez, R., and Norcross, M. A. (2001) Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages. J. Biol. Chem. 276, 49236-49243
36. Farzan, M., Babcock, G. J., Vasilieva, N., Wright, P. L., Kiprilov, E., Mirzabekov, T., and Choe, H. (2002) The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1α association and HIV-1 entry. J. Biol. Chem. 277, 29484-29489
37. Veldkamp, C. T., Seibert, C., Peterson, F. C., Sakmar, T. P., and Volkman, B. F. (2006) Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1α (SDF-1α/CXCL12). J. Mol. Biol. 359, 1400-1409
38. Huang, C. C., Lam, S. N., Acharya, P., Tang, M., Xiang, S. H., Hussan, S. S., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., Wyatt, R., Bewley, C. A., and Kwong, P. D. (2007) Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317, 1930-1934
39. Simpson, L. S., Zhu, J. Z., Widlanski, T. S., and Stone, M. J. (2009) Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides. Chem. Biol. 16, 153-161
40. Tan, J. H., Ludeman, J. P., Wedderburn, J., Canals, M., Hall, P., Butler, S. J., Taleski, D., Christopoulos, A., Hickey, M. J., Payne, R. J., and Stone, M. J. (2013) Tyrosine sulfation of chemokine receptorCCR2enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1). J. Biol. Chem. 288, 10024-10034
41. Zhu, J. Z., Millard, C. J., Ludeman, J. P., Simpson, L. S., Clayton, D. J., Payne, R. J., Widlanski, T. S., and Stone, M. J. (2011) Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3. Biochemistry 50, 1524-1534
42. Webb, L. M., and Alcami, A. (2005) Virally encoded chemokine binding proteins. Mini Rev. Med. Chem. 5, 833-848
43. Fong, A. M., Alam, S. M., Imai, T., Haribabu, B., and Patel, D. D. (2002) CX(3)CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion. J. Biol. Chem. 277, 19418-19423
44. Blackburn, P. E., Simpson, C. V., Nibbs, R. J., O'Hara, M., Booth, R., Poulos, J., Isaacs, N. W., and Graham, G. J. (2004) Purification and biochemical characterization of the D6 chemokine receptor. Biochem. J. 379, 263-272
45. Stone, M. J., Chuang, S., Hou, X., Shoham, M., and Zhu, J. Z. (2009) Tyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins. N. Biotechnol. 25, 299-317
46. Laarman, A. J., Mijnheer, G., Mootz, J. M., van Rooijen, W. J., Ruyken, M., Malone, C. L., Heezius, E. C., Ward, R., Milligan, G., van Strijp, J. A., de Haas, C. J., Horswill, A. R., van Kessel, K. P., and Rooijakkers, S. H. (2012) Staphylococcus aureus staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO J. 31, 3607-3619
47. Choe, H., Moore, M. J., Owens, C. M., Wright, P. L., Vasilieva, N., Li, W., Singh, A. P., Shakri, R., Chitnis, C. E., and Farzan, M. (2005) Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC). Mol. Microbiol. 55, 1413-1422
48. McCulloch, C. V., Morrow, V., Milasta, S., Comerford, I., Milligan, G., Graham, G. J., Isaacs, N. W., and Nibbs, R. J. (2008) Multiple roles for the C-terminal tail of the chemokine scavenger D6. J. Biol. Chem. 283, 7972-7982
49. Farzan, M., Chung, S., Li, W., Vasilieva, N., Wright, P. L., Schnitzler, C. E., Marchione, R. J., Gerard, C., Gerard, N. P., Sodroski, J., and Choe, H. (2002) Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region. J. Biol. Chem. 277, 40397-40402
50. Kwong, J. A., Dorfman, T., Quinlan, B. D., Chiang, J. J., Ahmed, A. A., Choe, H., and Farzan, M. (2011) A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein. J. Virol. 85, 7563-7571
51. Rot, A., McKimmie, C., Burt, C. L., Pallas, K. J., Jamieson, T., Pruenster, M., Horuk, R., Nibbs, R. J., and Graham, G. J. (2013) Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor. J. Immunol. 190, 6450-6456
52. Horuk, R. (2009) OPINION chemokine receptor antagonists: overcoming developmental hurdles. Nat. Rev. Drug Discov. 8, 23-33
53. Schall, T. J., and Proudfoot, A. E. (2011) Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat. Rev. Immunol. 11, 355-363